Continuation, reduction, or withdrawal of tofacitinib in patients with rheumatoid arthritis achieving sustained disease control: a multicenter, open-label, randomized controlled trial.
Chinese medical journal（2023）
摘要
Chictr.org, ChiCTR2000039799.
更多查看译文
关键词
rheumatoid arthritis,tofacitinib,sustained disease control,randomized controlled trial,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要